These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C]. García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422 [No Abstract] [Full Text] [Related]
24. Quality of life, anxiety and depression in ALS patients and their next of kin. Olsson Ozanne AG; Strang S; Persson LI J Clin Nurs; 2011 Jan; 20(1-2):283-91. PubMed ID: 21108676 [TBL] [Abstract][Full Text] [Related]
25. A prescription for unemployment? Recessions and the demand for mental health drugs. Bradford WD; Lastrapes WD Health Econ; 2014 Nov; 23(11):1301-25. PubMed ID: 23956154 [TBL] [Abstract][Full Text] [Related]
26. Wanted: a good night's sleep. Mosier WA; Nelson AS; Walgren KD Adv Nurse Pract; 1998 May; 6(5):30-5. PubMed ID: 9633287 [No Abstract] [Full Text] [Related]
27. Depression and anxiety. Miller K; Massie MJ Cancer J; 2006; 12(5):388-97. PubMed ID: 17034675 [TBL] [Abstract][Full Text] [Related]
28. Marine indole alkaloids: potential new drug leads for the control of depression and anxiety. Kochanowska-Karamyan AJ; Hamann MT Chem Rev; 2010 Aug; 110(8):4489-97. PubMed ID: 20380420 [No Abstract] [Full Text] [Related]
30. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O; Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403 [TBL] [Abstract][Full Text] [Related]
31. Ambulatory management in alcoholism. Bort RF Am Fam Physician; 1977 Nov; 16(5):131-4. PubMed ID: 21561 [TBL] [Abstract][Full Text] [Related]
32. Depression & Anxiety-SMi Conference. Shining light into dark corners. 12-13 May 2003, London, UK. Durrance A IDrugs; 2003 Jul; 6(7):664-7. PubMed ID: 12908452 [No Abstract] [Full Text] [Related]
33. [Treatment of anxious-depressive syndromes with tofizopam]. Novotný V; Molcan J; Sipkovská E; Knoíková M Act Nerv Super (Praha); 1979 Oct; 21(3):152-3. PubMed ID: 42263 [No Abstract] [Full Text] [Related]
34. Comparison of molindone and placebo in anxious depressed patients. Goldstein BJ; Brauzer B Curr Ther Res Clin Exp; 1971 Jun; 13(6):344-9. PubMed ID: 4397132 [No Abstract] [Full Text] [Related]
35. [Association between anxiolytic and antidepressant consumption and psychiatric symptoms in the elderly]. Alonso Formento E; Saz Muñoz P; Lobo Satué A; Ventura Faci T; De La Cámara Izquierdo C; Marcos Aragüés G Rev Esp Geriatr Gerontol; 2010; 45(1):10-4. PubMed ID: 20044171 [TBL] [Abstract][Full Text] [Related]
37. [Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors]. Koval'chuk VV Vopr Onkol; 2007; 53(6):704-10. PubMed ID: 18416142 [No Abstract] [Full Text] [Related]
38. Brief report: citalopram in child and adolescent depression with anxiety. Schaller JL; Behar D MedGenMed; 2001 Oct; 3(5):1. PubMed ID: 11698908 [No Abstract] [Full Text] [Related]